Dr. Nader Moazami, MD
Cardiothoracic Surgery (Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician)
- Medicare participating
At a glance
- Medical school
- Columbia University College of Physicians and Surgeons (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 17
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: Columbia University College of Physicians and Surgeons
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician primary
MN license 104715 · MN license 52690
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
Medical groups
- New York University (6,134 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 17
- Services billed
- 41
- Patients’ average age
- 62
| Service | Times | Patients |
|---|---|---|
| Transplantation of donor heart | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 5 payments worth $4,097 in total to this clinician.
| Octapharma USA, Inc. | $4,000 |
|---|---|
| Hikma Pharmaceuticals USA | $38.11 |
| Abbott Laboratories | $30.44 |
| Abiomed | $27.99 |
| Honoraria | $4,000 |
|---|---|
| Food and Beverage | $72.32 |
| Gift | $24.22 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Octapharma USA, Inc. Dec 16, 2025 | Honoraria FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY | $4,000 |
| Hikma Pharmaceuticals USA May 31, 2025 | Gift in-kind Company’s descriptionHikma Branded accessories during the IAMA event | $24.22 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $11,903 in research payments for these studies, mostly to the institutions running them.
- Preserve
Xvivo Perfusion Inc. - PSR-MCS
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.